Zobrazeno 1 - 10
of 88
pro vyhledávání: '"James J Schlesselman"'
Autor:
Jan P Vandenbroucke, Erik von Elm, Douglas G Altman, Peter C Gøtzsche, Cynthia D Mulrow, Stuart J Pocock, Charles Poole, James J Schlesselman, Matthias Egger, STROBE Initiative
Publikováno v:
PLoS Medicine, Vol 4, Iss 10, p e297 (2007)
Much medical research is observational. The reporting of observational studies is often of insufficient quality. Poor reporting hampers the assessment of the strengths and weaknesses of a study and the generalisability of its results. Taking into acc
Externí odkaz:
https://doaj.org/article/2ac6ac825ae841fc8c6fef9b56003f12
Autor:
Jan P. Vandenbroucke, Erik von Elm, Douglas G. Altman, Peter C. Gøtzsche, Cynthia D. Mulrow, Stuart J. Pocock, Charles Poole, James J. Schlesselman, Matthias Egger
Publikováno v:
The Ewha Medical Journal, Vol 47, Iss 2 (2024)
의학 연구의 대부분은 관찰 연구이다. 관찰 연구의 보고는 종종 불충분한 품질을 보이기도 한다. 부실한 보고는 연구의 강점과 약점을 평가하고 연구 결과의 일반화 가능성을 평가하는 데
Externí odkaz:
https://doaj.org/article/ab8d8cdea3f848ecaa673273264edc1f
Autor:
Jan P. Vandenbroucke, Erik von Elm, Douglas G. Altman, Peter C. Gotzsche, Cynthia D. Mulrow, Stuart J. Pocock, Charles Poole, James J. Schlesselman, Matthias Egger
Publikováno v:
Вопросы современной педиатрии, Vol 21, Iss 3, Pp 173-208 (2022)
Much medical research is observational. The reporting of observational studies is often of insufficient quality. Poor reporting hampers the assessment of the strengths and weaknesses of a study and the generalisability of its results. Taking into acc
Externí odkaz:
https://doaj.org/article/329d44bfb4814e1b8b91068b8b1f4ec0
Autor:
Jan P. Vandenbroucke, Erik Von Elm, Douglas G. Altman, Peter C. Gøtzsche, Cynthia D. Mulrow, Stuart J. Pocock, Charles Poole, James J. Schlesselman, Matthias Egger
Publikováno v:
Gaceta Sanitaria, Vol 23, Iss 2, Pp 158e1-158e28 (2009)
Gran parte de la investigación biomédica es de tipo observacional. Los informes de los estudios observacionales a menudo poseen una calidad insuficiente, lo que dificulta la evaluación de sus fortalezas y debilidades para generalizar los resultado
Externí odkaz:
https://doaj.org/article/12fd9caaa03542868be8e877b05f7313
Autor:
A. Ricart, E. Gabriella Chiorean, James J. Schlesselman, Khaled A. Tolba, Joseph D. Rosenblatt, Luis E. Raez, Kyriakos P. Papadopoulos, Metin Kurtoglu, Robert S. DiPaola, Donald Jung, Stewart Kroll, Mark N. Stein, V. K. Langmuir, Caio Max S. Rocha Lima, Theodore J. Lampidis
Publikováno v:
Cancer Chemotherapy and Pharmacology. 71:523-530
This phase I trial was initiated to evaluate the safety, pharmacokinetics (PK) and maximum tolerated dose (MTD) of the glycolytic inhibitor, 2-deoxy-D-glucose (2DG) in combination with docetaxel, in patients with advanced solid tumors.A modified acce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01996a6f99ba65cbc4c669a035c726ce
https://doi.org/10.1007/s00280-012-2045-1
https://doi.org/10.1007/s00280-012-2045-1
Autor:
Wassim McHayleh, Rajesh Sehgal, Robert L. Redner, Anastasios Raptis, Mounzer Agha, James Natale, The Minh Luong, James J. Schlesselman, Kennteh A. Foon, Michael Boyiadzis
Publikováno v:
Leukemia & Lymphoma. 50:1848-1853
The most effective regimen for patients with acute myeloid leukemia (AML) who do not achieve complete remission (CR) after one course of cytarabine and an anthracycline has not been extensively studied. We evaluated restrospectively the efficacy, tox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70d0f926f9a9c404f7af4049cf71739a
https://doi.org/10.3109/10428190903216788
https://doi.org/10.3109/10428190903216788
Autor:
Joanna M. Brell, Ramesh K. Ramanathan, James J. Schlesselman, Terry Evans, Linda Rath, S. Dranko, Amy Schmotzer, Khalid Matin, Robert Volkin, Gauri J. Kiefer, Diana Lenzner
Publikováno v:
Oncology. 76:270-274
Background: There is no standard second-line therapy for advanced pancreatic cancer (APC). We evaluated the epidermal growth factor receptor (EGFR) inhibitor gefitinib and docetaxel in a phase II study following gemcitabine failure. Methods: EGFR ove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f3ce5b62a3038ef120f68e8a9682fbf
https://doi.org/10.1159/000206141
https://doi.org/10.1159/000206141
Autor:
Hong Wang, Darcy Franicola, Joel S. Greenberger, Michael W. Epperly, James J. Schlesselman, Tracy Dixon
Publikováno v:
Radiation Research. 170:437-443
Epperly, M. W., Dixon, T., Wang, H., Schlesselman, J., Franicola, D. and Greenberger, J. S. Modulation of Radiation-Induced Life Shortening by Systemic Intravenous MnSOD-Plasmid Liposome Gene Therapy. Radiat. Res. 170, 437–443 (2008). To determine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f785c46791906dfc5688e038294ced6
https://doi.org/10.1667/rr1286.1
https://doi.org/10.1667/rr1286.1
Autor:
James J. Schlesselman
Publikováno v:
Journal of the Royal Society of Medicine. 109(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02aceabef57a2309858df6042d591bcb
https://pubmed.ncbi.nlm.nih.gov/26801994
https://pubmed.ncbi.nlm.nih.gov/26801994
Publikováno v:
American Journal of Obstetrics and Gynecology. 190:S5-S22
Since the introduction of hormonal contraceptives in the 1960s, there have been a variety of both health benefits and safety concerns attributed to their use. In most instances, the noncontraceptive benefits of oral contraceptives (OCs) outweigh the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4c19601f66d01283d9a08690b36e5f8
https://doi.org/10.1016/j.ajog.2004.01.061
https://doi.org/10.1016/j.ajog.2004.01.061